Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE)

Area of Science:

• Neuroimmunology
• Stem Cell Therapy
• Neurodegenerative Diseases

Background:

• Multiple sclerosis (MS) is a neurodegenerative disease characterized by demyelination and inflammation in the central nervous system, driven by an auto-reactive immune response.
• Mesenchymal stem cells (MSCs) are investigated for MS therapy due to their immunomodulatory, anti-inflammatory, and neuroprotective properties.
• Experimental autoimmune encephalomyelitis (EAE) is a widely used mouse model for studying MS pathology and testing potential therapies.

Purpose of the Study:

• To provide a comprehensive protocol for utilizing mesenchymal stem cells (MSCs) in the context of multiple sclerosis (MS) research.
• To guide scientists in the preparation and administration of MSCs for therapeutic intervention in the EAE mouse model.
• To detail methods for inducing EAE, evaluating disease progression, and analyzing tissues post-mortem.

Main Methods:

• Isolation, culturing, and expansion of mesenchymal stem cells (MSCs) from various sources.
• Induction of experimental autoimmune encephalomyelitis (EAE) in mice.
• Administration of MSC-based treatments and subsequent evaluation of disease markers and tissue pathology.

Main Results:

• Studies in the EAE model demonstrate that MSCs can ameliorate disease symptoms and pathology.
• MSCs exhibit migration to inflamed areas, release of anti-inflammatory factors, and neuroprotective effects.
• The described methods enable reproducible testing of stem cell therapies for MS.

Conclusions:

• Mesenchymal stem cells (MSCs) represent a viable therapeutic strategy for multiple sclerosis (MS).
• This chapter offers a practical framework for researchers to implement MSC-based therapies in MS preclinical models.
• Standardized protocols are crucial for advancing the understanding and treatment of MS.